Prostate Perform
Prostate Perform, licence 80073393: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Other names
- Prostate Fitness
- Licence holder
- New Roots Herbal Inc.
- NPN or DIN-HM
- 80073393
- Status
- Active licence
- Licence date
- 31 October 2016
- Revision date
- 5 February 2025
- Form
- Gélule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Serenoa repens (W.Bartram) Small: L'étiquetage doit comporter une mention recommandant de prendre conseil auprès d'un professionnel de santé ("Demander l'avis de votre médecin et /ou pharmacien").
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Urtica dioica L.: L'étiquetage des compléments alimentaires contenant les parties souterraines de cette plante doit comporter une mention recommandant de prendre conseil auprès d'un professionnel de santé ("Demander l'avis de votre médecin et /ou pharmacien").
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Secale cereale Source : Pollen extract Extraction ratio : 20:1 Dry plant equivalent : 2100 milligramme | 105.0 milligramme | Not calculated |
| Mélange de concentré de tocophérols Source : Glycine max - Graine | 38.0 milligramme | Not calculated |
| Stérols végétaux libres Source : Glycine max - Graine Potency : 70.0 milligramme beta-Sitosterol | 175.0 milligramme | Not calculated |
| Stérols végétaux libres Source : Glycine max - Graine Potency : 35.0 milligramme campesterol | Not specified | Not calculated |
| Stérols végétaux libres Source : Glycine max - Graine Potency : 35.0 milligramme stigmasterol | Not specified | Not calculated |
| Serenoa repens Source : Saw palmetto fruit lipidosterolic extract Potency : 95.0 % fatty acid | 160.0 milligramme | Not calculated |
| Pygeum africanum Source : Écorce Potency : 12.0 % phytosterols | 50.0 milligramme | Not calculated |
| Urtica dioica Source : Racine Extraction ratio : 20:1 Dry plant equivalent : 500 milligramme Potency : 5.0 % Silicic Acid | 25.0 milligramme | Not calculated |
| Sélénium Source : Sélénométhionine | 50.0 microgrammes | Not calculated |
| L-Alanine | 50.0 milligramme | Not calculated |
| Vaccinium macrocarpon Source : Fruit | 50.0 milligramme | Not calculated |
Non-medicinal ingredients
Huile de tournesol, Lécithine, Pumpkin seed oil, huile d'olive, Glycérine, Annatto extract, Eau purifiée, Gélatine, Cire d'abeille, Dioxyde de silicium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes de sexe masculin | minimum: 18.0 Année(s) | minimum: 1.0 Gélule ; maximum: 2.0 Gélule | 1.0 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Saw palmetto is used in Herbal Medicine to help relieve the urologic symptoms (e.g. weak urine flow, incomplete voiding, frequent daytime and night time urination) associated with mild to moderate benign prostatic hyperplasia. Stinging nettle is used in Herbal Medicine to help reduce difficulty in urination associated with the early stages of benign prostatic hyperplasia (BPH). Helps to maintain immune function. Provides antioxidants for the maintenance of good health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80073393
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
Has the product changed? Photograph the packaging.